The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an Italian patent for its Planar Thermal Circuit® invention.
Dish of the day:
No Joiners Today
Off the menu:
No Leavers Today
What’s cooking in the IPO kitchen?
The pantry is empty, again!
Banquet Buffet
SimiGon 7p £3.6m (SIM.L)
Establishment of a Mergers & Acquisitions (M&A) team. SimiGon’s M&A team, led by Chief Operating Officer, Jack Sarnicki, will perform financial and technical due diligence on suitable acquisitions. The Company is seeking to acquire simulation & training businesses that are aligned with the Company’s strategic focus in the Government and Commercial training and simulation market. “SimiGon is in the enviable position of having both the financial ability and support of key shareholders to make strategic business acquisitions that will help expand into key market segments” said Mr. Sarnicki.
Directa Plus 82p £50m (AIM:DCTA)
The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an Italian patent for its Planar Thermal Circuit® invention. The patent, covers the use of the G+® graphene circuit applied onto fabrics of any type and which is able to absorb body heat and move it from the hottest to the coldest point of the circuit, providing a significantly increased sense of comfort to the wearer or user.
Gama Aviation 46p £29.3m (GMAA.L)
The global business aviation service provider, together with Atkins, has been reappointed to continue delivering Military Airworthiness Reviews (MARs) to the Royal Air Force’s HQ Air Command (HQ Air) and The British Army’s Joint Helicopter Command.
Airworthiness regulations were issued by The Military Aviation Authority in 2013, requiring all aircraft on the UK Military Aircraft Register to be assessed by an independent organisation to ensure they are safe, airworthy and fit for development whenever they are most needed.
The reappointment means Gama Aviation and Atkins will continue the work they have been undertaking for the Ministry of Defence (MOD) since 2014, during which time more than 2,500 MARs have been completed across a wide range of battlefield helicopters, combat jets, large transport and intelligence-gathering aircraft, as well as training and vintage aircraft.
Synairgen 53p £79m (AIM:SNG)
The respiratory drug discovery and development company, today announces that it has launched an expansion of the SG016 trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients to dose patients in the home setting. The expansion of the trial aims to dose patients earlier in the illness, within three days of symptoms developing. This follows receipt of the necessary approvals to expand the ongoing SG016 trial from the original 100 patients, to include enrolling an…
Read More: Small Cap Wrap – Directa Plus, Synairgen, Frontier IP and more…